Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients

J Gene Med. 2024 Jan;26(1):e3613. doi: 10.1002/jgm.3613. Epub 2023 Oct 20.

Abstract

Background: Programmed cell death (PCD) is a natural process in which cells undergo controlled self-destruction, which plays a crucial role in maintaining tissue homeostasis and eliminating damaged or unnecessary cells. The connection between PCD and osteosarcoma was explored in the present study.

Methods: Twelve types of PCD were collected for developing a prognostic signature in osteosarcoma using machine learning algorithms. The prognostic value, pathway annotation and drug prediction of the signature were explored.

Results: Telomerase reverse transcriptase (TERT) was found to be a potent hazardous marker in osteosarcoma and could facilitate the proliferation and migration of osteosarcoma.

Conclusions: In summary, the present study has developed a prognostic signature for osteosarcoma and identifies TERT as a potent hazardous gene. The study suggests that further research is needed to address the underlying mechanism of how TERT affects the immune response in osteosarcoma.

Keywords: bioinformatics; bone cancer; osteology.

MeSH terms

  • Algorithms
  • Apoptosis
  • Bone Neoplasms* / drug therapy
  • Bone Neoplasms* / genetics
  • Cell Death / genetics
  • Humans
  • Osteosarcoma* / drug therapy
  • Osteosarcoma* / genetics